skip to the content

For Health Professionals

Faculty Research Activities

A. Kim Ritchey, MD

  • Principal Investigator, Children’s Oncology Group studies at Children’s Hospital if Pittsburgh
  • Hemostasis research, especially clinical thrombosis
  • Co-principal investigator of the phase I Consortium of the Children's Oncology Group, which conducts early phas clinical trials of novel agents in pediatric oncology.
  • Quality improvement analysis aimed at Improving the Scope and Quality of Bereavement Care for Families who have Suffered the Loss of a Child to Cancer.
  • Project aimed at Advancing Peditatric Resident Education in Pediatric Palliative and End-of-Life Care and Communication.
  • Comparison of Thrombosis Rates in Adolescent and Young Adult (AYA) Versus Younger Pediatric Oncology Patients.
 
 
 
  • Understanding the genetic variation and outcome of bone marrow transplantation, especially graft-versus-host-disease

J. Anthony Graves, MD, PhD

  • Focuses on understanding of some of the cellular modifications induced by overexpression of the c-Myc oncoprotein that ultimately result in development of tumors.
  • Institutional principal investigator for an industry sponsored clinical trial titled "Pilot study for standardization of diagnostic techniques for central venous catheters - Venous Thromboembolism Study".
  • Characterization of microRNA expression of platelets in Sickle Cell Disease.
  • Storage lesions in banked blood due to disruption of Nitric Oxide (NO) homeostasis.

Regina I. Jakacki, MD

  • Clinical neuro-oncology research through Children’s Oncology Group, Pediatric Brain Tumor Consortium and pharmaceutical investigations
  • Principal Investigator of the phase I consortium at Children’s Hospital of Pittsburgh

Lakshmanan Krishnamurti, MD

  • Curing sickle cell disease through non-myeloablative bone marrow transplantation
  • Enhance delivery of care to patients and carriers with sickle disease or trait
  • Pediatric Resident Palliative Care Curriculum
  • Measuring Practice Patterns of Withdrawal of Nonbeneficial Therapies in Pediatric ICU
  • Feasibility and Effectiveness of a Comprehensive Bereavement Program for Families Whose Children have Died from Cancer

Edward V. Prochownik, MD, PhD

  • Understanding the role of Myc oncoproteins in normal and malignant cell growth

Peter H. Shaw, MD

  • Manipulation of umbilical cord and peripheral blood stem cells to increase platelet precursors to improve platelet recovery following stem cell transplantation

Jean M. Tersak, MD

  • Clinical oncology research
  • Rituximab in the treatment of opsoclonus monoclonus syndrome
  • Late effects in childhood cancer
  • Delineating the Molecular Pathogenesis of the life-threatening disease of childhood Wiskott-Aldrich Syndrome (WAS).
 
Last Update
December 21, 2012
top
  • Increase/Decrease Text Size
  • Print This Page

Related Information

top
Last Update
December 21, 2012
top